The wait for the Covid-19 vaccine may be over soon, and according to sources, after the second phase of human trials of the vaccine in the country has passed, it is likely to be used on the frontline staff involved in the treatment of the coronavirus epidemic.
The human trials of India biotech vaccine Kovaxin made in the country will begin on Wednesday. Industry sources say that human trials of another vaccine involving coronavirus may begin in July. However, experts believe that even if the vaccine completes the third phase of clinical trials, it will still take at least a year to get marketing permission.
The first phase of testing primarily tests vaccine toxicity on a small population and typically takes a month or more. At the same time, its effect is seen in the second phase test and its dose is determined which may take about six months. If all goes well, some vaccines associated with Covid-19 may complete another level of human trials by the end of this year.
An industry source said, 'However, there is a possibility that after the completion of Phase II testing, at least the frontline staff, especially doctors and other health professionals, have no option of treatment in critical conditions. But the vaccine can be given. The source said that the information related to the vaccine's effect and its safety will be available from the second phase itself, and the third phase test can continue simultaneously. However, the local industry feels that even if the vaccine is used based on no other alternative, the vaccine will not be available before March next year.
A senior government official said that no decision has been taken yet. He said, 'We are closely monitoring the situation. It is important to protect the frontline employees. Also, plasma therapy is being used as a second option for serious patients and other trials are also underway. Therefore, we will take any decision at the right time only after the data related to human testing comes. But the safety of citizens is first.
Experts say this is an unprecedented situation. Rajiv Gandhi Biotechnology Center's Chief Scientific Officer E Srikumar says that the use of these drugs has been started in the event of no alternative and similarly these vaccines without approval should be used for high-risk groups. Can. Even if this happens, it can be considered only after the second phase of testing.
The industry believes that the vaccination campaign for the treatment of Covid 19 is a major task in the country. Even if only 10 percent of the country's population is vaccinated, it will still be 130 million doses. If two shots are needed in the vaccine, then it means that 26 crore doses will have to be produced. A vaccine manufacturer said it would take a few years before the whole of India is covered. This will be a huge task. The manufacturers believe that the Covid 19 vaccine will be a multiple shot vaccine.
Bharat Biotech has indicated that they will begin human trials from Wednesday and data on first phase trials will be introduced soon. However, the company has not given any deadline for this. On Monday, the company claimed that the Drug Controller General of India approved to start the first and second phase of human clinical trials when the company presented the results of pre-clinical (animal) studies that showed safety and immunity response. Gave it The SARS-COV-2 strain was separated into the National Institute of Virology, Pune, an institute under the Indian Council of Medical Research (ICMR) and transferred to Bharat Biotech. The fully indigenous, inactivated vaccine was developed at Bharat Biotech's Biosafety Level 3 plant in Hyderabad.
The race to produce the Covid 19 vaccine includes Cadila Healthcare in Ahmedabad, Rambana Biotech (with Rifana) in Delhi, and Serum Institute in Pune (along with AstraZeneca for the Oxford vaccine). Globally, Oxford-AstraZeneca, Moderna, and China's Synovac Biotech are also going to conduct large-scale trials in July. In this case, the competition will be very strong. Other sources in the industry say that the Drug Controller General of India has approved simultaneous Phase I and Phase II trials for the Bharat Biotech vaccine, indicating that the government also wants to speed it up.
Russia-Ukraine War: 'We do not live in an era of war', Danish Ambassador agrees with PM Modi's remarks
Russia-Ukraine War: On 24 February 2023, one year of Russia's attack on Ukraine will be completed. Meanwhile, US President Joe Biden suddenly reached the capital Kyiv and announced all possible help
Firing in Detroit: Three killed in a public shooting in Detroit, Michigan; Police looking for 'gunbaaz'
Police have arrested a suspect suspected of a violent shooting in Detroit, Michigan. Detroit Police said a gunman opened fire on four people in just two to two-and-a-half hours on Sunday morning,
Joshimath Sinking: Satellite pictures of ISRO revealed, Joshimath sunk 5.4 cm in 12 days
The National Remote Sensing Center of the Indian Space Research Organization has released satellite images of the Joshimath landslide for the first time. It is shown in the pictures that Joshimath
China does not want to reduce tension on LAC: Indian Army will also stand firm; ITBP to set up additional posts in Arunachal
After the 17th round of talks with China, it has become clear that it is not willing to reduce the tension in the border dispute. As a result, the Indian Army will still stand on the 3,488 km long LAC
Buy Samsung Galaxy F62 for the first time in the sale, these great offers are available on the phone
Smartphone company Samsung recently launched the new phone Samsung Galaxy F62 in the Indian market. At the same time, this great phone is the first cell today. That is, you can buy this phone from
Rahul Gandhi: Rahul Gandhi lashed out at the new draft of UGC, saying - this is a conspiracy to end reservation.
Congress leader Rahul Gandhi has termed the new draft guidelines of the University Grants Commission (UGC) as a conspiracy to end the reservation given to SC, ST, and OBC categories in higher
US President said, Russia cannot erase a sovereign country from the map; Appreciated the voting of UNGA
US President Joe Biden on Wednesday praised the vote against Russia and the resolution passed in the United Nations General Assembly (UNGA). The resolution condemned Russia's annexation of four
Weather Update: Weather is taking a turn, there is a possibility of rain in these parts of North India
The weather in North India may once again change. According to the Indian Meteorological Department, due to the new Western Disturbance, scattered rain and thundershowers may occur in parts of Punjab,
RBI receives bomb threat, mail in Russian language, police start investigation
The Reserve Bank of India has received a bomb threat. A threatening email came on the official website of the Reserve Bank of India on Thursday (12 December 2024) afternoon. This email was sent in
IND vs AUS: India will try to continue their winning streak against Australia, Virat-Zampa will compete, knowing the playing 11
An exciting Super-8 match will be played between India and Australia on Monday. A tough competition will be seen between the two teams at the Darren Sammy National Cricket Stadium in Gros Islet. The
